P1–349: A phase II double‐blind, placebo‐controlled randomized trial of an escalating dose of thalidomide in the treatment of Alzheimer's disease: Baseline characteristics. (1st July 2013) - Sabbagh, Marwan; Decourt, Boris; Liebsack, Carolyn; Sirrel, Sherye; Walker, Aaron; Gonzales, Amanda; Macias, Mimi; Jacobson, Sandra; Malek‐Ahmadi, Michael; Belden, Christine